Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69874 |
LLS30
|
||
LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 decreases Gal-1 binding affinity to its binding partners, and potentially overcomes metastatic castration-resistant prostate cancer (mCRPC). |